Study on the Registration of Coronary Heart Disease Patients Undergoing PCI
NCT02888652
·
clinicaltrials.gov ↗
COMPLETED
Status
1500
Enrollment
OTHER
Sponsor class
Conditions
Coronary Heart Disease
Interventions
DRUG:
antiplatelet agents(Clopidogrel or Ticagrelor)
Sponsor
The Third Xiangya Hospital of Central South University